Edwards Lifesciences Corporation Stock

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse 16:00:02 2024-07-12 EDT 5-day change 1st Jan Change
90.99 USD -2.00% Intraday chart for Edwards Lifesciences Corporation -1.44% +19.33%
Sales 2024 * 6.56B 8.94B Sales 2025 * 7.17B 9.77B Capitalization 55.95B 76.25B
Net income 2024 * 1.61B 2.2B Net income 2025 * 1.88B 2.56B EV / Sales 2024 * 8.28 x
Net cash position 2024 * 1.64B 2.23B Net cash position 2025 * 2.75B 3.75B EV / Sales 2025 * 7.42 x
P/E ratio 2024 *
35.2 x
P/E ratio 2025 *
30 x
Employees 19,800
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.59%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.00%
1 week-1.44%
Current month-1.49%
1 month+3.67%
3 months+0.79%
6 months+22.91%
Current year+19.33%
More quotes
1 week
90.89
Extreme 90.89
95.25
1 month
85.12
Extreme 85.12
95.25
Current year
71.67
Extreme 71.67
96.12
1 year
60.57
Extreme 60.57
96.12
3 years
60.57
Extreme 60.57
131.73
5 years
51.51
Extreme 51.5067
131.73
10 years
14.01
Extreme 14.0083
131.73
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 14-12-31
Director of Finance/CFO 57 13-12-31
Chief Tech/Sci/R&D Officer - 19-01-31
Members of the board TitleAgeSince
Director/Board Member 63 16-07-04
Chairman 67 14-11-12
Director/Board Member 72 16-03-15
More insiders
Date Price Change Volume
24-07-12 90.99 -2.00% 3,488,075
24-07-11 92.85 -0.99% 3,057,105
24-07-10 93.78 +0.32% 2,419,738
24-07-09 93.48 +1.79% 2,227,138
24-07-08 91.84 -0.52% 1,941,280

Delayed Quote Nyse, July 12, 2024 at 04:00 pm

More quotes
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.99 USD
Average target price
96.16 USD
Spread / Average Target
+5.69%
Consensus